![]() | FDA approval of pemigatinib for R/R myeloid/lymphoid neoplasms: a major advance in the field Süre: 3:23 | Boyut: 7.74 MB |
![]() | Dr. Chari on the FDA Approval of Belantamab Mafodotin in R/R Multiple Myeloma Süre: 0:48 | Boyut: 1.83 MB |
![]() | FDA Approves Revumenib, Gene Therapy Approval, Machine Learning Screening Tool Süre: 6:42 | Boyut: 15.34 MB |
![]() | FDA D.I.S.C.O. Burst Edition: FDA approves Rylaze (asparaginase erwinia chrysanthemi (recombinant... Süre: 3:31 | Boyut: 8.05 MB |
![]() | FDA approval of teclistamab for R/R multiple myeloma and the value of immunotherapies Süre: 0:45 | Boyut: 1.72 MB |
![]() | How FDA approval of over-the-counter Narcan sales affects the opioid crisis Süre: 6:49 | Boyut: 15.6 MB |
![]() | FDA approves marketing of e-cigarette products for those trying to quit smoking Süre: 2:15 | Boyut: 5.15 MB |
![]() | Dr Nowakowski on the FDA Approval of Epcoritamab in R/R Follicular Lymphoma Süre: 1:06 | Boyut: 2.52 MB |
![]() | Terminal Patients Got Drugs Without FDA Approval. It Added Years to Their Lives. Süre: 11:41 | Boyut: 26.74 MB |